THYROID GLAND MEDULLARY CARCINOMA
Clinical trials for THYROID GLAND MEDULLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID GLAND MEDULLARY CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID GLAND MEDULLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shrinks thyroid tumors before surgery in early trial
Disease control OngoingThis study tests whether giving the drug selpercatinib before surgery can shrink thyroid cancers that have a specific genetic change (RET alteration). About 30 people with advanced or recurrent thyroid cancer will receive the drug and then have surgery. The goal is to see if the …
Matched conditions: THYROID GLAND MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:00 UTC
-
New hope for kids with rare cancers: drug blocks tumor growth
Disease control OngoingThis study tests a daily pill called cabozantinib in children and young adults (up to age 30) with rare cancers like sarcomas, Wilms tumor, and others that have come back or not responded to treatment. The drug works by blocking signals that help tumors grow and form blood vessel…
Matched conditions: THYROID GLAND MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New imaging agent spots hidden cancers
Diagnosis OngoingThis pilot study tests a special PET scan that uses a radioactive tracer (64Cu-M5A) to find cancers that produce a protein called CEA. The goal is to see if this scan can detect tumors that standard methods might miss. About 20 adults with breast, colon, lung, or other CEA-positi…
Matched conditions: THYROID GLAND MEDULLARY CARCINOMA
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated May 26, 2026 09:00 UTC